.AN2 Therapies is actually reviewing its business in response to uninspired midphase data, vowing to...
.Merck & Co. is spending $700 million in advance to test Amgen in a blood cancer market. The barg...
.With Gilead Sciences almost an FDA selection for its liver ailment medicine seladelpar, the provide...
.Chief executive officer David Ricks can observe the companies putting together camping tents at bas...
.Bed Liquidators has actually switched Entero Therapies white colored as a sheet. The lender got Ent...
.Exelixis is losing hope on its own cells factor (TF)- targeting antibody-drug conjugate after wrapp...
.Three weeks after Roche's Genentech unit ignored an SHP2 inhibitor pact, Relay Rehab has actually v...
.Stoke Therapies' Dravet disorder drug has actually been actually devoid of a partial hold, getting ...
.Fierce Biotech Affiliate Editor Gabrielle Masson provided the 2024 course of Intense 15 victors on ...
.Novo Nordisk has actually axed its once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) prog...